Clinical Trial Update: Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of buprenorphine for non-dependent opiate users has completed. The study was sponsored by the National Institute on Drug Abuse (NI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 1 | Status: COMPLETED